Sign up to save your podcasts
Or
Share Residual tumor volume and survival after CCNU/TMZ in GBM
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Residual tumor volume and survival after CCNU/TMZ in GBM
Dr. Iyad Alnahhas interviews Drs. Thomas Zeyen and Johannes Weller about their recent manuscript entitled: "Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with CCNU/TMZ", published online in Neuro-Oncology in October 2024.
View all episodes
By Neuro-Oncology
4.8
1212 ratings
Dr. Iyad Alnahhas interviews Drs. Thomas Zeyen and Johannes Weller about their recent manuscript entitled: "Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with CCNU/TMZ", published online in Neuro-Oncology in October 2024.
More shows like Neuro-Oncology: The Podcast
View all
Wait Wait... Don't Tell Me!
38,689 Listeners
This American Life
90,949 Listeners
Neurology® Podcast
288 Listeners
Science Vs
12,103 Listeners
Radio Atlantic
2,321 Listeners
Armchair Expert with Dax Shepard
69,085 Listeners
Call Her Daddy
165,721 Listeners
Conan O’Brien Needs A Friend
59,349 Listeners
The Cribsiders
317 Listeners
IMO with Michelle Obama and Craig Robinson
12,348 Listeners
Huberman Lab
28,494 Listeners
The Ezra Klein Show
15,335 Listeners
If Books Could Kill
8,874 Listeners
Not Gonna Lie with Kylie Kelce
9,964 Listeners
Good Hang with Amy Poehler
7,654 Listeners